The Parkinson's Genetic Research Study (PaGeR)

May 11, 2024 updated by: Cyrus Zabetian, University of Washington

The Parkinson's Genetic Research Study (PaGeR)

The Parkinson's Genetic Research Study (PaGeR), headed by Dr. Cyrus Zabetian, is searching for genes that increase the risk of developing Parkinson's disease (PD) and related disorders. The study is a joint effort by neurologists and researchers across the United States and is sponsored by the National Institutes of Health. The coordinating center for PaGeR is located at the University of Washington and the VA Puget Sound Health Care System in Seattle.

Study Overview

Status

Recruiting

Conditions

Detailed Description

PaGeR is focusing on families in which two or more people have been diagnosed with PD. Past research suggests that such "multiplex" families might hold the key to the discovery of new PD genes.

To take part in PaGeR, participants will be asked to complete a questionnaire and to undergo an interview, a neurological exam, a short memory test, and a blood draw. Enrollment in the study usually takes between one and two hours. There is no cost to participate, and all study information is kept strictly confidential.

There are a number of designated sites across the country where families can enroll. However, for family members who are unable to travel to one of these sites, other arrangements can be made.

Study Type

Observational

Enrollment (Estimated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Jennifer Pate
  • Phone Number: 1-855-646-4221

Study Contact Backup

  • Name: Khryss Capawa
  • Phone Number: (206) 277-3956
  • Email: kcapawa@uw.edu

Study Locations

    • Georgia
      • Atlanta, Georgia, United States, 30329
        • Recruiting
        • Emory University/ Wesley Woods Health Center
        • Contact:
    • Ohio
      • Cincinnati, Ohio, United States, 45267
        • Recruiting
        • University of Cincinnati
        • Contact:
    • Oregon
      • Portland, Oregon, United States, 97239
        • Recruiting
        • Portland VA Medical Center
        • Contact:
          • Susan O'Connor
          • Phone Number: 53262 503-220-8262
    • Washington
      • Seattle, Washington, United States, 98108
        • Recruiting
        • VA Puget Sound Health Care System
        • Contact:
          • Jennifer Pate
          • Phone Number: 855-646-4221
        • Principal Investigator:
          • Cyrus Zabetian, MD, MS
      • Seattle, Washington, United States, 98118
        • Recruiting
        • University of Washington
        • Contact:
          • Jennifer Pate
          • Phone Number: 855-646-4221
        • Principal Investigator:
          • Cyrus Zabetian, MD, MS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Families in which two or more people have been diagnosed with Parkinson's disease.

Description

Inclusion Criteria:

  • Over 18 years of age
  • Member of a family in which there are two or more living individuals who have been diagnosed with Parkinson's disease

Exclusion Criteria:

  • Under 18 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Family-Based
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Case
Has a diagnosis of Parkinson's disease
Control
No diagnosis of Parkinson's disease
Family Member
Has a family history of Parkinson's disease. Can be affected or unaffected with Parkinson's disease

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cyrus Zabetian, MD, MS, University of Washington, VA Puget Sound Health Care System

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2009

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

October 31, 2026

Study Registration Dates

First Submitted

March 16, 2012

First Submitted That Met QC Criteria

March 16, 2012

First Posted (Estimated)

March 20, 2012

Study Record Updates

Last Update Posted (Actual)

May 14, 2024

Last Update Submitted That Met QC Criteria

May 11, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease

Subscribe